Clinical Trial Update: Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia [NA]

View source ↗

Summary

A terminated clinical trial investigating the effects of transdermal nicotine on response inhibition to emotional cues in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impulsive Behavior
• Schizophrenia

Drugs mentioned

• nicotine (transdermal) (nicotine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Schizophrenia, Impulsive Behavior | NA | Status: TERMINATED | Results posted: 2022-04-29